Emerging Role of Dual GLP-1 and GIP Receptor Agonists | DMSO
GLP-1 receptor agonists in type 2 diabetes: An underused asset? Updated January 2021 - DiabetesontheNet
Novel Pharmacological Approaches to the Treatment of Type 2 Diabetes | Pharmacological Reviews
Treatment of type 2 diabetes with incretin-based therapies - The Lancet
GLP-1 receptor agonists used to treat type 2 diabetes* | Download Table
2 Medikamentöse Therapie des Glukosestoffwechsels — Leitlinien.de
Glucagon-like Peptide-1 Plasmid Construction and Delivery for the Treatment of Type 2 Diabetes: Molecular Therapy
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
GLP-1 receptor agonist for type 2 diabetes - Clinical Advisor
A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism - ScienceDirect
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial - The Lancet
How Does GLP-1 Affect Diabetes?
Glucagon Like Peptide 1 (GLP-1) Agonist Drugs for Type 2 Diabetes | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives
Biology | Free Full-Text | Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches
GLP-1 gene delivery for the treatment of type 2 diabetes: Molecular Therapy
Treatment of Type 2 Diabetes mellitus (T2DM): Can GLP-1 Receptor Agonists fill in the gaps? | Sharma | Chemical Biology Letters
Neue Diabetemedikamente Typ-2-Diabetes - diabetes-news : diabetes-news
GLP-1 Agonist Effects on Glucagon Suppression
Kidney and Dialysis | Free Full-Text | GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease
Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors | The Review of Diabetic Studies
Glucagon-like peptide-1 - Wikipedia
Neue Diabetemedikamente Typ-2-Diabetes - diabetes-news : diabetes-news
Therapeutic potential of GLP-1 in type 2 diabetes mellitus | Download Table
JCI Insight - Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes
Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors
Molecular mechanisms redirecting the GLP-1 receptor signalling profile in pancreatic β-cells during type 2 diabetes
The role of GLP-1 and GIP in glucose homeostasis. Key defects in... | Download Scientific Diagram
Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia | Science Advances
Medikamente gegen Typ-2-Diabetes: GLP-1-Analoga | Apotheken Umschau
